+1 (619) 956-9114 info@myicfos.com
Follow us
Arise BioPharma
Location: Newport Beach - 3/19/24, 1:20 PM - 3/19/24, 1:30 PM (US/Pacific) (10 minutes)

Arise BioPharma
Gaytri Kachroo
CEO of ARISE BioPharma Inc at ARISE BioPharma
+1 774-232-2865
CEO of ARISE BioPharma Inc at ARISE BioPharma
+1 774-232-2865

Dr. Gaytri Kachroo is an accomplished legal scholar with a PhD from the Harvard Law School. Dr. Kachroo is a highly accomplished general counsel and has acted in senior executive management roles for the past 20 years in biopharma and finance. Prior successes have been marked in her experience as a high-profile congressional counsel, fraud litigator, international regulatory experience, and as corporate transactional attorney in technology, life sciences, and finance.


Arise BioPharma Inc. (Arise) is a wholly-owned subsidiary of Peptide Account LLC. Arise holds property rights to several late-stage compounds targeting neuro-degenerative illnesses. It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.